Following an annual appraisal of our progress, we are happy to announce that the MPN Foundation has decided to renew our project funding for one additional year. The funding supports a collaborative research project between the HI-STEM Experimental Hematology Group, and the groups of Dr. Steven Lane at the Queensland Institute for Medical Research in Brisbane, Australia, and Ann Mullally at the Dana-Faber Cancer Institute/Brigham and Women’s Hospital in Boston, USA.
Dr. Ruzhica Bogeska has been selected to give a talk at the European School of Hematology’s 3rd Scientific Workshop on "The Hematological Microenvironment and its Therapeutic Targeting", which will be held at the Francis Crick Institute in London on February 24-26th 2019. The Workshop features talks from internationally renowned experts in normal and malignant hematology and will be a great opportunity for Ruzhica to showcase her work on the impact of inflammatory stress on hematopoietic stem cell function.
Further details at www.esh.org/conference/3rd-scientific-workshop-tumour-microenvironment-in-the-haematological-malignancies-and-its-therapeutic-targeting/
Julius was selected to present at the International Behr-Symposium on Stem Cells and Cancer (Heidelberg, Sept. 16-19), which is organized by HI-STEM.
Further details at www.scc2018.de
Congratulations to Sina Stäble on being awarded a talk at the forthcoming annual conference of the German Stem Cell Network, which will take place in September.
Ms. Stäbles abstract titled "Unidirectional and progressive DNA methylation changes define hematopoietic lineage commitment" has been selected for an oral presentation at the 6th GSCN Conference in Heidelberg (19.-21.9.2018), Session Computational Stem Cell Biology on Wednesday, 19 Sept. 14:30 - 16:00 h.
Further details at http://www.gscn.org/conferences/2018/home.aspx
Dr. Mick Milsom has been elected on to the Board of Directors for the International Society for Experimental Hematology (ISEH), for a three year term.
